Proteocyte AI

Improve OPMD Care & Outcomes

STRATICYTE’s® advanced digital pathology leverages biomarker analysis to go ‘beyond standard’ and help answer one of healthcare’s most important questions: Who is most at risk?

Go beyond standard, with STRATICYTE®

👉 https://proteocyte.com/


American Academy of Otolaryngology—Head and Neck Surgery American Academy of Oral Medicine American Academy of Oral and Maxillofacial Pathology - AAOMP American Association of Oral and Maxillofacial Surgeons - AAOMS American Cancer Society

Go Beyond Pathology

Pathology can only tell you what a lesion is, but STRATICYTE® can tell you where it’s going.

STRATICYTE® dives deeper with biomarker analysis and cytomorphometrics for a personalized 5-year window to Oral Cancer Risk.

Look Deeper, See Farther – with STRATICYTE®: https://proteocyte.com/straticyte/


Nova Scotia Dental Association Ontario Dental Association Ontario Society of Oral and Maxillofacial Surgery The Terry Fox Foundation The Princess Margaret Cancer Foundation

SPOT IT. TEST IT.

When it comes to oral cancer, early detection is key.

Some lesions may be low-risk, while others are higher risk of becoming cancerous. Catching it early can help transform patient care and treatment outcomes.

STRATICYTE® goes beyond traditional pathology for a personalized assessment of your 5-year oral cancer risk.

Take charge of your oral health.

Ask your doctor about STRATICYTE® today.

https://proteocyte.com/straticyte/patients/


Canadian Dental Association Canadian Partnership Against Cancer Société de recherche sur le cancer / Cancer Research Society Fondation québécoise du cancer Manitoba Dental Association NB Dental Society Newfoundland and Labrador Dental Association

Look Deeper, See Farther with STRATICYTE®.

What if cancer care could be predictive?

That question inspired the creation of STRATICYTE®

STRATICYTE® goes beyond conventional histopathology with advanced digital analysis, and tailored algorithms, to uncover deeper insight to your patient’s individual OSCC risk.

Our goal is simple – identify risk early to support better OPMD patient care and outcomes.

STRATICYTE®: Predict Oral Cancer Risk

Visit proteocyte.com to learn more.


Alberta Dental Association Association des chirurgiens dentistes du Québec - ACDQ BC Cancer Foundation BC Dental Association CancerCare Manitoba Canadian Association of Oral and Maxillofacial Surgeons Canadian Cancer Society

Go Beyond ConventionalPathology with STRATICYTE®.

The biopsy is already there – opportunity for deeper insight is too.

STRATICYTE® uses a patient’s existing biopsy specimen for an objective, personalized 5-year OSCC risk, to help guide surveillance, intervention, and treatment planning.

✔ Use existing biopsy
✔ Personalized 5-year OSCC Risk Score
✔ Objective risk stratification

Learn how STRATICYTE® can help improve OPMD care and outcomes.
👉 https://proteocyte.com/straticyte/


Seattle Jaw Surgery Society of OMS Administrators SPOHNC Mouth Cancer Foundation Oral Health Foundation SurgeOn Events

Spot It. Test It.

If you or your doctor notice an oral lesion, knowing your individual risk can help you & your healthcare provider make informed decisions about what comes next.

STRATICYTE’s® personalized 5-year Oral Cancer Risk Score uses your existing tissue sample for testing — no additional biopsy needed.

For Precision. For Peace of Mind.

Ask your healthcare provider about STRATICYTE®. Learn more:
👉 https://proteocyte.com/straticyte/patients/


American Dental Association Beacon Oral & Maxillofacial Surgeons Everyday Oral Surgery Head and Neck Cancer Alliance Osteo Science Foundation Oral Cancer Foundation Paradigm Oral Health

Not every oral potentially malignant disorder (OPMD) carries the same risk.

STRATICYTE® provides an objective, personalized 5-year oral cancer risk score, helping clinicians identify patients who may benefit from closer surveillance while supporting more appropriate management of lower-risk lesions.

More clarity. More confidence. Better patient care.

Learn more:
👉 https://proteocyte.com/straticyte/


American Academy of Otolaryngology—Head and Neck Surgery American Academy of Oral Medicine American Academy of Oral and Maxillofacial Pathology - AAOMP American Association of Oral and Maxillofacial Surgeons - AAOMS American Cancer Society

Integrating STRATICYTE® into your clinical workflow is simple.

Your role is simple: Order the Test by completing the Test Request Form (TRF)- https://proteocyte.com/ordering-options/

Our Role: Proteocyte AI contacts the pathology lab where the original biopsy tissue resides to request tissue samples from the original specimen – NO EXTRA BIOPSY REQUIRED

Using the existing biopsy specimen, our team performs advanced biomarker analysis and digital pathology to generate a personalized 5-year oral cancer risk assessment.

No additional surgery. No added complexity.

Just the insight you need to support more confident clinical decisions.

Learn more:
👉 https://proteocyte.com/straticyte/


Nova Scotia Dental Association Ontario Dental Association Ontario Society of Oral and Maxillofacial Surgery The Terry Fox Foundation The Princess Margaret Cancer Foundation

Peace of mind starts with knowing the risk.

For patients diagnosed with an Oral Potentially Malignant Disorder (OPMD), uncertainty can be one of the most difficult parts of the journey.

STRATICYTE® helps reduce that uncertainty by providing an objective, personalized 5-year oral cancer risk score, giving clinicians and patients greater confidence when making care decisions.

Because peace of mind begins with better information.

Learn more: proteocyte.com


Seattle Jaw Surgery Society of OMS Administrators SPOHNC Mouth Cancer Foundation Osteology Foundation Oral Health Foundation SurgeOn Events

Traditional histopathology is an essential part of oral lesion assessment—but it doesn't always tell the full story.

STRATICYTE® supplements histology with AI-driven biomarker analysis and digital pathology, providing an objective, personalized 5-year oral cancer risk score to support more informed clinical decision-making.

✔ Objective risk assessment
✔ Personalized patient management
✔ No additional biopsy required

Learn how STRATICYTE® can support your practice:
👉 https://proteocyte.com/straticyte/


Canadian Dental Association Canadian Partnership Against Cancer Société de recherche sur le cancer / Cancer Research Society Fondation québécoise du cancer Manitoba Dental Association NB Dental Society Newfoundland and Labrador Dental Association